ES2118033B1 - Formulacion farmaceutica antiinflamatoria. - Google Patents

Formulacion farmaceutica antiinflamatoria.

Info

Publication number
ES2118033B1
ES2118033B1 ES09600374A ES9600374A ES2118033B1 ES 2118033 B1 ES2118033 B1 ES 2118033B1 ES 09600374 A ES09600374 A ES 09600374A ES 9600374 A ES9600374 A ES 9600374A ES 2118033 B1 ES2118033 B1 ES 2118033B1
Authority
ES
Spain
Prior art keywords
weight
pharmaceutically acceptable
pharmaceutical formulation
inflammatory
nanoemulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09600374A
Other languages
English (en)
Other versions
ES2118033A1 (es
Inventor
Pelaez Ricardo Palacios
Lopez Carlos Ruiz-Bravo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roxall Medicina Espana SA
Original Assignee
Bial Industrial Farmaceutica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Industrial Farmaceutica SA filed Critical Bial Industrial Farmaceutica SA
Priority to ES09600374A priority Critical patent/ES2118033B1/es
Priority to PCT/ES1997/000238 priority patent/WO1999016424A1/es
Publication of ES2118033A1 publication Critical patent/ES2118033A1/es
Application granted granted Critical
Publication of ES2118033B1 publication Critical patent/ES2118033B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORMULACION FARMACEUTICA ANTIINFLAMATORIA. FORMULACION FARMACEUTICA QUE CONTIENE UN EUTOMERO DE AL MENOS UN PRINCIPIO ACTIVO ANTIINFLAMATORIO, QUIRAL E HIDROINSOLUBLE, CON UN PH FISIOLOGICAMENTE ACEPTABLE, EN FORMA DE NANOEMULSION. LA NANOEMULSION CONTIENE 3 A 50% EN PESO DE UN SOLVENTE ORGANICO FARMACEUTICAMENTE ACEPTABLE, NO MISCIBLE EN AGUA, DE CARACTER APOLAR Y NO-IONICO QUE CONSTITUYE LA FASE INTERNA DE LA NANOEMULSION; 5 A 45% EN PESO DE UN AGENTE SURFACTANTE NO-IONICO FARMACEUTICAMENTE ACEPTABLE; 5 A 30% EN PESO DE UN AGENTE CO-SURFACTANTE NO-IONICO FARMACEUTICAMENTE ACEPTABLE; 5 A 87% EN PESO DE AGUA O DE UNA SOLUCION TAMPON FARMACEUTICAMENTE ACEPTABLE; COMO INGREDIENTE ACTIVO, 0,1 A 1,0% EN PESO DE UN EUTOMERO DE AL MENOS UN PRINCIPIO ANTIINFLAMATORIO, QUIRAL E HIDROINSOLUBLE; 0 A 6,5% DE AL MENOS UN EXCIPIENTE COMPLEMENTARIO FARMACEUTICAMENTE ACEPTABLE. EL INGREDIENTE ACTIVO ESTA VEHICULADO EN DISOLUCION MOLECULAR EN EL SOLVENTE ORGANICO.
ES09600374A 1996-02-16 1996-02-16 Formulacion farmaceutica antiinflamatoria. Expired - Fee Related ES2118033B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES09600374A ES2118033B1 (es) 1996-02-16 1996-02-16 Formulacion farmaceutica antiinflamatoria.
PCT/ES1997/000238 WO1999016424A1 (es) 1996-02-16 1997-09-30 Formulacion farmaceutica antiinflamatoria

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09600374A ES2118033B1 (es) 1996-02-16 1996-02-16 Formulacion farmaceutica antiinflamatoria.
PCT/ES1997/000238 WO1999016424A1 (es) 1996-02-16 1997-09-30 Formulacion farmaceutica antiinflamatoria

Publications (2)

Publication Number Publication Date
ES2118033A1 ES2118033A1 (es) 1998-09-01
ES2118033B1 true ES2118033B1 (es) 1999-07-01

Family

ID=26154947

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09600374A Expired - Fee Related ES2118033B1 (es) 1996-02-16 1996-02-16 Formulacion farmaceutica antiinflamatoria.

Country Status (2)

Country Link
ES (1) ES2118033B1 (es)
WO (1) WO1999016424A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
CA2142103C (en) * 1992-08-28 2003-07-08 Haim Aviv Submicron emulsions as ocular drug delivery vehicles
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.

Also Published As

Publication number Publication date
ES2118033A1 (es) 1998-09-01
WO1999016424A1 (es) 1999-04-08

Similar Documents

Publication Publication Date Title
ES8608875A1 (es) Un metodo para preparar una composicion farmaceutica para aplicacion topica que contiene 1-dodecilazacicloheptan-2-ona.
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DE60019902D1 (de) Echinocandin pharmazeutische zusammensetzungen
SV2002000969A (es) Composicion parenteral reconstituible
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ATE226815T1 (de) Herstellung von arzneimitteln
ES2179052T3 (es) Composicion farmaceutica que contiene un derivado de ciclosporina.
BRPI0311877B8 (pt) formulação farmacêutica ácida de insulina com estabilidade aperfeiçoada
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
PE20040103A1 (es) Metodo y formas de dosificacion para incrementar la solubilidad de composiciones de farmaco para administracion controlada
CO5231147A1 (es) Composicion congelante
ATE179884T1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
CO5280073A1 (es) Composiciones
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
ES2123721T3 (es) Formulaciones de rapamicina para inyecciones por via intravenosa.
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
ATE367165T1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
AR041936A1 (es) Formulacion micelar acuosa que comprende un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales de los mismos en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas y
KR950007857A (ko) 경구투여용 라파마이신 제제

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980901

Kind code of ref document: A1

Effective date: 19980901

PC2A Transfer of patent
FA2A Application withdrawn

Effective date: 20001108

FD2A Announcement of lapse in spain

Effective date: 20180807